Clinical and CMR characteristics | Number (of n=124) | Percentage (%) |
---|---|---|
Age | 55 | - |
M:F | 56:70 | 45% male, 55% female |
Patients with at least one cardiac abnormality | 100 | 83 |
Thinned LV myocardium | 8 | 5 |
LV dilatation | 24 | 19 |
LV wall motion abnormality | 40 | 32 |
LVH | 31 | 25 |
Raised LV mass index | 23 | 19 |
Reduced LV long axis fx | 37 | 30 |
LV EF<45% | 15 | 12 |
RV dilatation | 30 | 24 |
Reduction in RV EF | 25 | 20 |
RVH | 22 | 22 |
Reduced RV long axis function | 22 | 17 |
Pericardial effusion | 20 | 16 |
LA enlargement (>moderate) | 27 | 22 |
RA enlargement (>moderate) | 29 | 23 |
Dilated PA | 45 | 36 |
Increased signal on T2-STIR | 1 | <1% |
Late gadolinium enhancement | 26 | 21 |
Patients with only 1 cardiovascular abnormality on CMR | 16 | 13 |
Patients with 2 cardiovascular abnormalities on CMR | 17 | 13 |
Patients with 4 or more cardiovascular abnormalities on CMR | 57 | 46 |